MAPP
Map Pharmaceuticals Inc
Biopharmaceutical company developing novel therapies to address unmet patient needs in neurology
CUSIP: 56509R108HealthcareUS1 holder
Map Pharmaceuticals Inc
Biopharmaceutical company developing novel therapies to address unmet patient needs in neurology
No insider transactions reported in the last 3 years. Look across all recorded history →